| 11279710 |
Processes for preparing ACC inhibitors and solid forms thereof |
Michael L. Geier, Luke D. Humphreys |
2022-03-22 |
$347,175,000 |
| 10815214 |
Regioselective N-2 arylation of indazoles |
Cheol K. Chung, Paul Gerard Bulger, Kevin M. Belyk, John Limanto, Guy R. Humphrey |
2020-10-27 |
$370,448,000 |
| 10745412 |
Processes for preparing ACC inhibitors and solid forms thereof |
Luke D. Humphreys |
2020-08-18 |
$748,849,000 |
| 10689369 |
Substituted indazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, B. Wesley Trotter +1 more |
2020-06-23 |
$115,870,000 |
| 10519165 |
Processes for preparing ACC inhibitors and solid forms thereof |
Michael L. Geier, Norihiro Ikemoto, Sean Liew, Vimal Varghese |
2019-12-31 |
$178,096,000 |
| 10487090 |
Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof |
Selcuk Calimsiz, Michael L. Geier, Geraldine C. Harriman, Jon P. Lawson, Kyle Sabourin +3 more |
2019-11-26 |
|
| 10435386 |
Regioselective N-2 arylation of indazoles |
Cheol K. Chung, Paul Gerard Bulger, Kevin M. Belyk, John Limanto, Guy R. Humphrey |
2019-10-08 |
$87,533,000 |
| 10344000 |
Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, Danielle F. Molinari +3 more |
2019-07-09 |
$88,734,000 |
| 10287272 |
Substituted indazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, B. Wesley Trotter +1 more |
2019-05-14 |
$81,943,000 |
| 10072025 |
Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors |
David Joseph Guerin, Danielle F. Molinari, Sam Kattar, Peter H. Fuller, Christopher J. Dinsmore +5 more |
2018-09-11 |
$76,678,000 |
| 10059705 |
Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors |
Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Jason Katz, Christopher F. Thompson +9 more |
2018-08-28 |
$100,134,000 |
| 9957264 |
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Peter H. Fuller, David Joseph Guerin, Jason Katz, Qinglin Pu +11 more |
2018-05-01 |
$129,774,000 |
| 9957265 |
N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors |
Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Christopher F. Thompson, Qinglin Pu +11 more |
2018-05-01 |
$129,774,000 |
| 9725445 |
Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors |
Matthew L. Childers, Christopher J. Dinsmore, Peter H. Fuller, David Joseph Guerin, Jason Katz +14 more |
2017-08-08 |
$65,756,000 |
| 9580407 |
Regioselective N-2 arylation of indazoles |
Cheol K. Chung, Paul Gerard Bulger, Kevin M. Belyk, John Limanto, Guy R. Humphrey |
2017-02-28 |
$88,591,000 |
| 9486448 |
Pyrrolidine derived beta 3 adrenergic receptor agonists |
Kenneth J. Barr, Christopher F. Thompson, Neville J. Anthony, Carolyn Michele Cammarano, Raman K. Bakshi +6 more |
2016-11-08 |
$82,214,000 |
| 8993756 |
Pyrrolopyrimidines as janus kinase inhibitors |
Sean P. Ahearn, Matthew Christopher, Christopher J. Dinsmore, Joon Jung, Qinglin Pu +4 more |
2015-03-31 |
$66,424,000 |
| 8937077 |
Bicyclic diamines as janus kinase inhibitors |
David Joseph Guerin, Jason D. Brubaker, Michelle Martinez, Joon Jung, Neville J. Anthony +5 more |
2015-01-20 |
$161,539,000 |
| 8604038 |
Pyrrolidine derived beta 3 adrenergic receptor agonists |
Scott D. Edmondson, Lehua Chang, Nam Fung Kar, Gergori J. Morriello, Christopher Moyes +9 more |
2013-12-10 |
$69,974,000 |
